Greg Harrison

Stock Analyst at B of A Securities

(4.62)
# 228
Out of 5,042 analysts
101
Total ratings
63.64%
Success rate
20.53%
Average return

Stocks Rated by Greg Harrison

United Therapeutics
Sep 2, 2025
Maintains: Neutral
Price Target: $314$463
Current: $418.58
Upside: +10.61%
Mineralys Therapeutics
Aug 28, 2025
Maintains: Buy
Price Target: $38$43
Current: $39.90
Upside: +7.77%
Travere Therapeutics
Aug 7, 2025
Maintains: Sector Outperform
Price Target: $30$31
Current: $28.06
Upside: +10.48%
Ocular Therapeutix
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $22$20
Current: $11.49
Upside: +74.06%
BridgeBio Pharma
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $55$57
Current: $54.26
Upside: +5.05%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Sector Perform
Price Target: $442$438
Current: $421.39
Upside: +3.94%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Sector Outperform
Price Target: $342$450
Current: $463.43
Upside: -2.90%
Agios Pharmaceuticals
Jul 28, 2025
Maintains: Sector Outperform
Price Target: $71$65
Current: $43.33
Upside: +50.01%
Rocket Pharmaceuticals
Jul 25, 2025
Downgrades: Neutral
Price Target: $9$4
Current: $3.85
Upside: +3.90%
Gossamer Bio
Jul 14, 2025
Initiates: Sector Outperform
Price Target: $11
Current: $2.48
Upside: +343.55%
Maintains: Sector Outperform
Price Target: $32$35
Current: $11.22
Upside: +211.94%
Maintains: Sector Outperform
Price Target: $65$55
Current: $29.22
Upside: +88.23%
Maintains: Sector Outperform
Price Target: $36$37
Current: $22.38
Upside: +65.33%
Maintains: Sector Outperform
Price Target: $41$26
Current: $15.04
Upside: +72.87%
Maintains: Sector Perform
Price Target: $28$20
Current: $28.17
Upside: -29.00%
Downgrades: Sector Perform
Price Target: $4$1.5
Current: $1.24
Upside: +20.97%
Upgrades: Sector Outperform
Price Target: $40
Current: $27.96
Upside: +43.06%
Maintains: Sector Outperform
Price Target: $73$75
Current: $85.63
Upside: -12.41%
Initiates: Sector Outperform
Price Target: $18
Current: $11.98
Upside: +50.25%
Maintains: Buy
Price Target: $89$91
Current: $25.60
Upside: +255.47%
Upgrades: Neutral
Price Target: $9$12
Current: $32.28
Upside: -62.83%
Downgrades: Underperform
Price Target: $5$1.5
Current: $0.63
Upside: +136.85%
Maintains: Neutral
Price Target: $18$15
Current: $3.72
Upside: +303.23%
Downgrades: Underperform
Price Target: $3
Current: $7.55
Upside: -60.26%
Initiates: Buy
Price Target: $70
Current: $2.08
Upside: +3,265.38%
Maintains: Buy
Price Target: $67$54
Current: $17.65
Upside: +205.95%
Downgrades: Underperform
Price Target: $270$90
Current: $60.10
Upside: +49.75%